Wedbush Securities Inc Dr Reddys Laboratories LTD Transaction History

Wedbush Securities Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 08, 2021	SELL	$60.19 - $75.29 $166,605 - $208,402	-2,768 Closed	0 $0
Q2 2021 Jul 27, 2021	BUY	$62.12 - $74.2 $171,948 - $205,385	2,768 New	2,768 $203,000
Q2 2020 Jul 16, 2020	SELL	$39.55 - $54.65 $243,469 - $336,425	-6,156 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$34.82 - $39.26 $383 - $431	11 Added 0.18%	6,156 $233,000
Q2 2019 Aug 01, 2019	BUY	$36.05 - $42.76 $1,261 - $1,496	35 Added 0.57%	6,145 $230,000
Q1 2019 Apr 17, 2019	SELL	$35.77 - $40.57 $393 - $446	-11 Reduced 0.18%	6,110 $247,000
Q4 2018 Jan 31, 2019	BUY	$31.89 - $38.44 $2,040 - $2,460	64 Added 1.06%	6,121 $231,000
Q3 2018 Nov 13, 2018	BUY	$29.25 - $36.73 $177,167 - $222,473	6,057 New	6,057 $210,000
Q2 2018 Aug 03, 2018	SELL	$28.49 - $35.06 $186,808 - $229,888	-6,557 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$30.11 - $37.72 $197,431 - $247,330	6,557	6,557 $234,000

245

23.2M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.56B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.